Endometrial Cancer

Showing NaN - NaN of 36

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Endometrial Cancer Trial in United States (oxaliplatin)

Completed
  • Endometrial Cancer
  • Birmingham, Alabama
  • +37 more
Jun 20, 2013

Endometrial Cancer, Sarcoma Trial in Canada, United States (pegylated liposomal doxorubicin HCl)

Completed
  • Endometrial Cancer
  • Sarcoma
  • pegylated liposomal doxorubicin hydrochloride
  • Birmingham, Alabama
  • +48 more
Jun 7, 2013

Endometrial Cancer Trial in United States (pegylated liposomal doxorubicin HCl)

Completed
  • Endometrial Cancer
  • pegylated liposomal doxorubicin hydrochloride
  • Orange, California
  • +9 more
Jun 7, 2013

Endometrial Cancer Trial in Canada, United States (danazol)

Completed
  • Endometrial Cancer
  • Birmingham, Alabama
  • +72 more
Jun 7, 2013

Endometrial Cancer Trial in Norway, United States (medroxyprogesterone)

Terminated
  • Endometrial Cancer
  • Tucson, Arizona
  • +30 more
Jun 7, 2013

Endometrial Cancer Trial in Canada, United States (irofulven)

Completed
  • Endometrial Cancer
  • Birmingham, Alabama
  • +39 more
May 24, 2013

Quality of Life in Survivors of Gynecologic Cancer

Completed
  • Endometrial Cancer
  • Ovarian Cancer
  • quality-of-life assessment
  • Birmingham, Alabama
  • +43 more
May 24, 2013

Endometrial Cancer Trial in United States (conjugated estrogens)

Terminated
  • Endometrial Cancer
  • conjugated estrogens
  • Birmingham, Alabama
  • +148 more
Apr 10, 2013

Endometrial Cancer Trial in Canada, United States (filgrastim, cisplatin, doxorubicin HCl)

Terminated
  • Endometrial Cancer
  • filgrastim
  • +5 more
  • Birmingham, Alabama
  • +49 more
Apr 10, 2013

Endometrial Cancer Trial in Worldwide (BEZ235)

Withdrawn
  • Endometrial Cancer
  • Phoenix, Arizona
  • +58 more
Jun 20, 2012

Ovarian Cancer, Endometrial Cancer, Cervical Cancer Trial in Nashville (pemetrexed, topotecan)

Completed
  • Ovarian Cancer
  • +3 more
  • Nashville, Tennessee
    Tennessee Oncology, PLLC
Jan 22, 2009